Q BioMed Inc. (QBIO)

OTCMKTS: QBIO · Delayed Price · USD
0.0003
0.00 (0.00%)
Mar 21, 2024, 12:06 PM EDT - Market closed

Total Valuation

Q BioMed has a market cap or net worth of $43,528.

Market Cap 43,528
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Q BioMed has 145.10 million shares outstanding.

Shares Outstanding 145.10M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 2.99%
Owned by Institutions (%) n/a
Float 140.88M

Valuation Ratios

The trailing PE ratio is 0.01 and the forward PE ratio is 111.11.

PE Ratio 0.01
Forward PE 111.11
PS Ratio 2.90
Forward PS n/a
PB Ratio n/a
P/FCF Ratio 0.02
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 5,744.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee $5,012
Profits Per Employee $492,020
Employee Count 3
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

In the past 12 months, Q BioMed has paid $107,723 in taxes.

Income Tax 107,723
Effective Tax Rate 6.80%

Stock Price Statistics

The stock price has decreased by -97.97% in the last 52 weeks. The beta is 79.93, so Q BioMed's price volatility has been higher than the market average.

Beta (1Y) 79.93
52-Week Price Change -97.97%
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 55.79
Average Volume (30 Days) 60,601

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Q BioMed had revenue of $15,035 and earned $1.48 million in profits. Earnings per share was $0.04.

Revenue 15,035
Gross Profit -67,667
Operating Income 2.14M
Pretax Income 1.58M
Net Income 1.48M
EBITDA 2.16M
EBIT 2.14M
Earnings Per Share (EPS) $0.04
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity / Book Value n/a
Book Value Per Share n/a
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow 2.53M
Capital Expenditures n/a
Free Cash Flow 2.53M
FCF Per Share $0.02
Full Cash Flow Statement

Margins

Gross margin is -450.06%, with operating and profit margins of 14,212.50% and 9,817.49%.

Gross Margin -450.06%
Operating Margin 14,212.50%
Pretax Margin 10,512.07%
Profit Margin 9,817.49%
EBITDA Margin 14,378.78%
EBIT Margin 14,212.50%
FCF Margin 16,823.60%

Dividends & Yields

Q BioMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 3,391.06%
FCF Yield 5,811.04%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on August 7, 2015. It was a forward split with a ratio of 2.5:1.

Last Split Date Aug 7, 2015
Split Type Forward
Split Ratio 2.5:1

Scores

Altman Z-Score n/a
Piotroski F-Score 3